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A  direct  correlation  of  QEMG  with  muscle  biopsy  findings 
might  help  delineate  the  sensitivity  of  QEMG  in  identifying 
muscle pathology as well as provide information on electro-
physiological-histological correlations. In a study of 31 patients 
with a variety of myopathies we found that the sensitivity of 
QEMG was between 24 to 69% depending of the specific meth-
od of signal analysis. The positive predictive value of abnormal 
QEMG was more than 90% while its negative predictive value 
was only about 20%. Amplitude outlier analysis was superior 
especially in minimally weak muscles (MRC > 4) and was par-
ticularly sensitive at detecting increased variability in fiber size 
and more subtle myopathic changes. 
Key words: Quantitative electromyography, muscle biopsy, sensi-
tivity
Introduction 
Quantitative  electromyographic  (QEMG)  analysis 
can be a useful tool in the investigation of muscle disease. 
It may be used to select a muscle suitable for biopsy and 
to sample individual muscles periodically to monitor dis-
ease activity (1, 2).
The sensitivity and specificity of QEMG in myopa-
thies have been the subject of several studies which have 
used the clinical diagnoses as the gold (3-7). However 
there is only a handful of studies that have directly cor-
related QEMG with findings on muscle biopsy (8-10). 
Further knowledge on direct correlations between QEMG 
and biopsy would help delineate the sensitivity of the 
former in predicting histological abnormalities.
In the current study we correlate QEMG with biopsy 
findings in the contralateral muscle in a group of 31 pa-
tients referred for neuromuscular evaluation and in which a 
final clinical diagnosis of myopathy was finally reached. 
Methods
Patients
We retrospectively identified 39 patients, referred to 
the Cyprus Institute of Neurology and Genetics for neu-
romuscular evaluation between the period 1999 and 2001. 
During this time period patients suspected of a myopa-
thy had both a QEMG and muscle biopsy as part of their 
routine work up. An abnormal QEMG was not required 
for a patient to proceed to biopsy. All patients exhibited 
proximal  weakness  and/or  hyperCKemia.  Twenty  two 
patients had a Medical research council (MRC) > 4 and 
17 an MRC ≤ 4 in the muscle in which the QEMG was 
performed. All patients had symmetrical clinical involve-
ment of the muscles under investigation. In all 39 patients 
a final clinical diagnosis was reached (Table 1). In 31 the 
final diagnosis was myopathy.
Electromyography
A Nicolet Viking II was used to record motor unit ac-
tion potentials via a concentric needle (Medtronic DCN 
37mm,0,46mm) using the QMUP mode. MUAPs were 
manually selected using signal trigger averaging with the 
patient exerting a weak to moderate effort so as to activate 
2 to 5 MUAPs clearly seen on the baseline. Every effort 
was made to improve sharpness. The filters were set be-
tween 2 Hz to 10 kHz; the acquisition sensitivities were 
set at 100-500 μv/division and 5 ms/division.
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The duration of the MUAPs was determined manu-
ally after averaging at 100 μv/division and 5 ms/divi-
sion. Polyphasic MUAPs, but not satellite potentials, 
were included in the analyses. MUAPs with amplitude 
lower  than  50μV  and  rise  time  longer  than  500μsec 
were  rejected.  Twenty  MUAPs  were  obtained  from 
each  muscle  from  4-5  insertion  points.  The  original 
stored  data  consisting  of  20  averaged  MUAPs  from 
each muscle were re-analyzed for the purpose of this 
study using the mean duration and outlier methods and 
the results correlated with biopsy findings in the con-
tralateral muscle. 
For the mean duration method, the duration of 20 
MUAPs from each muscle were averaged and the mean 
compared with normal values for age (3, 11). A muscle 
was categorized as neuropathic or myopathic if the mean 
MUAP duration was 20% above or below the mean nor-
mal values for age respectively. 
The 20 MUAPs were also analyzed by the outliers 
method (12). Outliers as defined by Stalberg are the up-
per or lower MUAP amplitude or duration values beyond 
which a normal individual has no more than 2 MUAPs. 
For the outliers method we used the upper and lower limit 
values of Oh (13). MUAPs less than 6μsecs in duration 
and /or less than 300μV in amplitude were defined as my-
opathic, while MUAPs longer than 17msec in duration 
and/or larger than 3,5mV in amplitude as neuropathic. 
Muscles with more than 2 MUAPs outside the limits were 
considered abnormal. 
Muscle biopsies 
Open muscle biopsies were obtained from 20 vastus 
lateralis and 19 biceps brachii muscles.
The biopsy was obtained from the contralateral mus-
cle to that examined by QEMG. The selected muscle had 
a Medical research council (MRC) score more than 3. 
The pathologist reading the biopsies was not aware of the 
EMG result.
Muscle biopsy findings were classified for the pur-
pose of the study as myopathic; M1, increased variability 
in muscle fibre size involving both fibre types, M2, the 
presence of necrosis and/or regeneration, M3, the pres-
ence of endomysial fibrosis indicating chronicity and fi-
bre loss and M4 alterations in the fibre architecture with-
out significant fibre loss or variability in fibre size. Such 
abnormalities included ragged red and cytochrome c oxi-
dase deficient fibres (Fig. 1). Biopsies were classified as 
neurogenic if there were angular atrophic fibres of both 
fibre types and/or the presence of type grouping, indica-
tive of reinnervation (Fig. 1). 
Figure 1. Myopathic (M1, M2, M3, M4) and neuropathic 
(N1,N2) biopsy findings. For details see text. Asterix in 
M4 indicates a ragged red fibre.
table 1. Clinical diagnoses and biopsy findings.
Muscle biopsy findings*





All M1 M2 M3 M4
Inflammatory myopathies (n = 5) 5 5 4 1
HyperCKemia (n = 2) 2
Muscular dystrophy (n = 5) 5 4 1 3
Myotonic dystrophy (n = 2) 2 2 1
Inclusion body myositis (n = 1) 1 1 1
Non-specific myopathy (n = 9) 7 5 1 2 2
Mitochondrial myopathy (n = 9) 9 6 2 1 5
Motor neuron disease (n = 3) 3
Lumbar canal stenosis (n = 1) 1
Normal (n = 2) 2
Total number 39 29 23 7 6 9 3 7
Myopathic biopsies could exhibit more than one myopathic feature M1,2,3,4Correlation of QEMG with biopsy findings
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sensitivity
The sensitivity of the QEMG was calculated with ref-
erence to the biopsy findings in the contralateral muscle. 
We calculated the sensitivity of the mean duration and 
outlier QEMG methods separately. The sensitivity of each 
QEMG method was also evaluated separately in patients 
with an MRC > 4 and MRC ≤ 4.
Sensitivity was defined as the proportion of true posi-
tives divided by the sum of true positive and false nega-
tive results. 
Specificity could not be estimated since we did not 
include any real normal individuals in our study.
Predictive value
The positive predictive value of QEMG, defined as 
the likelihood of an abnormal QEMG predicting an ab-
normal biopsy, was calculated.
The negative predictive value of QEMG, defined as 
the likelihood that a normal QEMG will predict a normal 
biopsy, was calculated. 
Statistical analyses
The sensitivities between the different methods were 
compared using the nonparametric McNemar test for re-
lated samples (14). 
results
Patients 
The  clinical  diagnoses  and  biopsy  findings  of  the 
original 39 patients are shown in table 1. Thirty one pa-
tients were diagnosed to have a myopathy. Twenty nine 
exhibit myopathic features in their biopsy while two had 
a normal appearance in the biopsy but were weak and had 
elevated  creatine  kinase. Two  patients  were  diagnosed 
to  have  idiopathic  hyperCKemia,  four  had  neurogenic 
disorders and two were normal. The statistical analyses 
concern the QEMG-biopsy correlations in the 31 patients 
with a clinical diagnosis of myopathy. 
Sensitivity of QEMG 
The  sensitivity  of  QEMG  analyses  was  evaluated 
against the biopsy findings and is shown in Table 2.
The highest sensitivity (68,9%) in detecting a myo-
pathic biopsy was obtained using the amplitude outlier 
method  (MUP  amplitude  of  <  300μv). The  sensitivity 
of the amplitude outlier method was superior to the du-
ration outlier (p = 0,000) and mean duration methods 
(p = 0.007). 
Sensitivity of QEMG in relation to MRC score
The QEMG data were re-examined according to the 
MRC score of the muscle in which the QEMG was per-
formed (Table 3). 
For MRC > 4 the amplitude outlier method was again 
significantly  more  sensitive  than  the  duration  outlier 
method (p = 0.002) and also significantly more sensitive 
than the mean duration method (p = 0.021). For MRC ≤ 4 
there was no significant difference in sensitivity among 
the three methods. 
Predictive values
The positive and negative predictive values for each 
of the three methods of analyses are shown in Table 4. All 
three methods of analyses have similar positive and nega-
tive predictive values.
Relationship of QEMG to biopsy findings
As can be seen in Table 5 for any given method of 
analysis there were no significant differences in the sen-
sitivity in detecting the various (M1, M2, M3, M4) his-
tological subdivisions (all p-values > 0,05 based on Chi-
squared tests). 
In the pure M4 category (the most subtle of the myo-
pathic abnormalities), the amplitude outlier method was 
significantly  more  sensitive  than  the  duration  outlier 
(p = 0,000 and p = 0.000 respectively).





table  3.  Sensitivity  of  Q-EMG  methods  according  to 
MRC score.
MRC > 4 MRC ≤ 4
Sensitivity  Sensitivity
 (n = 29) (n=16) (n=13)
Classical Q-EMG 18,7% 46,1%
Amplitude outliers 68,7% 69,2%
Duration outliers 6,2% 46,1%
table 4. Predictive values of Q-EMG methods.
PPV NPV
Classical Q-EMG 100% 21%
Amplitude outliers 95% 33%
Duration outliers 87.5% 19%
Positive predictive value; PPV Negative predictive value; NPVE. Dardiotis et al.
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Discussion 
The primary aim of the study was to correlate QEMG 
and pathological findings in the biopsy of the contralateral 
muscle in patients with muscle disease. Although ideally 
the correlation should have been done in the same muscle 
this would not have been pragmatic since current practice 
is to perform the EMG on one side and do the biopsy on the 
contralateral muscle to avoid the risk of needle myopathy. 
We also examined the spectrum of histological abnormali-
ties that are associated with abnormalities on QEMG.
We have found the amplitude outlier method to be 
the most sensitive in identifying myopathic abnormali-
ties  with  a  sensitivity  of  69%.The  positive  predictive 
value of QEMG i.e. the likelihood of abnormal biopsy 
if the QEMG is abnormal is very high (87.5-100%). The 
number of patients with a normal biopsy is perhaps too 
small to perhaps give valid negative predictive values. 
For the outlier methods of analyses we have arbitrar-
ily used the cut of reference values from Oh which are 
the values we normally use for qualitative MUAP analy-
sis (13). We are aware that the method we have used to 
extract MUAP introduces a bias towards low threshold 
motor units but we made a special effort to vary the win-
dow trigger to capture MUAP of various amplitudes as 
long as the rise time was < 500μsec. The latter require-
ment ensured that the needle was very close to the firing 
muscle fiber and the MUAP amplitude greatly influenced 
by the diameter of the closest fiber.
Although different absolute values for the outliers 
have been used, derived using the multi-MUAP extraction 
method other studies have also identified the amplitude 
outlier analysis as a sensitive method for myopathies. A 
recent study on facioscapulohumeral muscular dystrophy 
found that in the milder affected vastus lateralis the am-
plitude outlier method was 33% sensitive compared to a 
10% of the duration outlier method (15). Similarly, in a 
smaller study of 8 patients with myopathies the amplitude 
outlier method was 75% sensitive compared to 25% and 
37,5% of the duration outlier and mean duration meth-
ods (12).
This difference in sensitivity between the various 
QEMG methods in our study could perhaps be explained 
by the sequence of histological changes commonly seen 
in the biopsy of most slowly evolving myopathies. Ini-
tially there is increasing variability in fibres size due to 
round atrophy involving both fibre types (16). As the 
myopathy becomes more severe there is gradual loss 
of muscle fibres and replacement with endomysial con-
nective tissue (17). In addition to fibre loss there may 
be compensatory increase in the diameter of surviving 
fibres  (work  hypertrophy)  (16).  Superimposed  on  the 
above changes there may be various amount of necrosis 
and regeneration.
The amplitude of the MUAP is determined by 5-12 
fibres within a 0,5 mm radius of the recording needle 
tip, while MUAP duration is determined by the number 
of fibres within a 2,5 mm radius of the recording needle 
tip (18). As atrophic fibres begin to appear within the 0,5 
mm radius of the recording tip this will cause a reduction 
in MUAP amplitude. As the myopathy progresses and 
there is random loss of fibres will there be shortening of 
the MUAP duration. 
Our patients were mostly in the early stages of clini-
cal involvement and only 6 out 31 patients exhibited fibre 
loss as evidenced by the presence of increased endomy-
sial tissue (M3). This perhaps explains the higher sensi-
tivity demonstrated by the amplitude outlier method. 
There  were  no  significant  differences  in  detecting 
the various histological abnormalities (M1, M2, M3, and 
M4) for any one of the three QEMG methods. Since vari-
ability in fiber size (M1) was present in most of the biop-
sies one can speculate that this histological feature alone 
drives the sensitivity of each of the method of analysis. 
Our study is in keeping with the view that EMG can not 
be reliably correlated with specific features in the mus-
cle biopsy. Previous studies examining QEMG and mus-
cle biopsy have documented a correlation only between 
long duration motor unit potential and regenerating fib-
ers (9, 10). 
No formal morphometry on the biopsies was carried 
out in our study, such as deriving atrophy or hypertro-
table 5. Sensitivity of various Q-EMG criteria according 
to biopsy findings.
Myopathic findings 
in muscle biopsy 
(n = 29)
Sensitivity
Classical Q-EMG All (n = 29) 31,0%
M1 (n = 23) 39,1%
M2 (n = 7) 28,6%
M3 (n = 6) 33,3%
M4 (n = 9) 22,2%
M4 without M1 (n = 5) 0%
Amplitude outliers All (n = 29) 68,9%
M1 (n = 23) 69,5%
M2 (n = 7) 71,4%
M3 (n = 6) 50%
M4 (n = 9) 77,7%
M4 without M1(n = 5) 80%
Duration outliers All (n = 29) 24,1%
M1 (n = 23) 30,4%
M2 (n = 7) 14,3%
M3 (n = 6) 33,3%
M4 (n = 9) 11,1%
M4 without M1 (n = 5) 0%Correlation of QEMG with biopsy findings
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phy factors, since this is not routinely practiced in our 
laboratory.
There are many other limitations to our study includ-
ing its retrospective nature and the small numbers of pa-
tients. However it was based on material acquired on a 
pragmatic approach in the investigation of patients. The 
ideal study would have been prospective and should have 
included patients in which the QEMG and biopsy are per-
formed sequentially in the same muscle. In addition in 
interpreting the findings of this study the sampling errors 
both of QEMG and that of the muscle biopsy need to be 
kept in mind. 
In summary, based on our data, we conclude that the 
amplitude outlier method of analysis may be the most 
sensitive method in picking up myopathy at its very earli-
est stage. 
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